Huller Kelly 4

What Happened

Kelly Huller, EVP, General Counsel and Corporate Secretary of Globus Medical (GMED), exercised 10,000 stock options at an exercise price of $45.64 on Feb 12, 2026 (cost $456,400) and on the same day sold 10,000 shares in an open-market transaction at $87.67 per share for total gross proceeds of $876,700. The Form 4 also reports a disposal of 10,000 derivative shares at $0; the filing does not provide further explanation for that line.

Key Details

• Transaction dates: February 12, 2026 (reported on Form 4 filed Feb 17, 2026). Note: Form 4 was filed 5 days after the transactions. Form 4s are typically due within two business days, so this filing is later than the usual reporting window.
• Option exercise: 10,000 shares exercised at $45.64 each (total $456,400). Options were granted Feb 2, 2018 and are fully vested (footnote F2).
• Sale: 10,000 shares sold at $87.67 each for $876,700; sale was executed pursuant to a Rule 10b5-1 trading plan dated Nov 12, 2025 (footnote F1).
• Report also shows a derivative disposal of 10,000 shares at $0; filing provides no additional detail on that entry.
• Shares owned after the transaction: not specified in the provided excerpt of the filing.

Context

• Because the exercise and sale occurred the same day, this resembles a cashless exercise where options are converted and the resulting shares are sold immediately to realize proceeds/net the exercise cost.
• The sale was executed under a pre-established 10b5-1 plan, which is a common mechanism insiders use to sell shares according to a predetermined schedule and can indicate the trade was pre-planned rather than a spontaneous market-timing decision.
• Facts only — this summary does not speculate about motivations.